5 Best Small Cap Pharma Stocks to Invest In

2. Esperion Therapeutics, Inc. (NASDAQ:ESPR)

Number of Hedge Fund Investors In Q4 2023: 28

Esperion Therapeutics, Inc. (NASDAQ:ESPR) is a Michigan based firm developing medicine to help people with low cholesterol. The firm has beaten analyst EPS estimates in three out of its four latest quarters and the shares are rated Buy on average.

Insider Monkey’s December quarter of 2023 survey covering 933 hedge funds revealed that 28 had invested in the firm. Esperion Therapeutics, Inc. (NASDAQ:ESPR)’s largest investor among these is Sina Toussi’s Two Seas Capital due to its $22.9 million investment.

Follow Esperion Therapeutics Inc. (NASDAQ:ESPR)